Strong demand for memory (data storage) cards and advanced chips has tightened global supplies and supported higher prices in past quarters...

Anupam Rasayan India Ltd has achieved a global first by commercialising Ethyl trifluoroacetate production using its unique continuous flow ...

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...

Gujarat is introducing a new 'ultra mega' industry category. This requires at least Rs 10,000 crore investment and 3,000 jobs. The state is...

America has released a new list of Chinese companies it believes support Beijing's military. Major firms like Alibaba, Baidu, and BYD are i...

The U.S. has updated its list of Chinese companies aiding Beijing's military, adding tech giants like Alibaba and Baidu, alongside chipmake...

Indian businesses face mounting pressure from soaring oil, freight, and insurance costs. Companies are increasing prices and reducing produ...

Vahh Chemicals' Initial Public Offering opens for subscription on Thursday. Grey market indicators suggest robust investor interest. The co...

Australia is suing US company 3M for AU$2 billion. The lawsuit concerns contamination from firefighting foam containing 'forever chemicals'...

European shares neared an all-time high, boosted by strong auto and chemical stocks, despite ongoing Middle East tensions. Investors are ca...

At a time when the markets are focused on war, crude oil, inflation, and supply disruption, it is easy to miss a quieter shift. India’s eng...

Dipan Mehta advises selective investing, favoring power infrastructure, export manufacturing, and specialty chemicals. While acknowledging ...

Twelve companies are set to go ex-dividend on Friday, offering shareholders payouts totaling over Rs 250. Bajaj Auto leads with a Rs 150 pe...

A prolonged West Asia conflict poses a risk to India Inc's profitability. Crisil Ratings predicts a significant drop in operating margins d...

Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with a...

Investors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...

Memory prices are set to rise for consumers. No major new production capacity is expected in the next 18 months. This will lead to higher c...